Abstract
To the Editor. — Endothelin-1 (ET-1) is a 21-residue vasoconstrictor-pressor peptide originally isolated and sequenced from porcine aortic endothelial cells. 1 We have recently demonstrated the production of ET-like immunoreactivity (LI) by renal tubular cells and the presence of ET-LI in human urine. 2 We have further shown that urinary ET-LI excretion levels remarkably increased in patients with renal disease, which originates, at least in part, from the affected renal tubules. 3 To elucidate whether urinary ET-LI is a marker for tubular injury, we measured urinary excretion levels of ET-LI in patients treated with cisplatin, a chemotherapeutic agent that often causes renal tubular damage. Study. — The present group consisted of six patients (three men and three women aged 50.0 ±6.4 years, mean± SEM) with cancers of various origins: adenocarcinoma of lung (two patients), ovarian papillary cystadenocarcinoma (two), lung metastasis of mandibular carcinoma (one), and mediastinal germ cell tumor (one).
Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callMore From: JAMA: The Journal of the American Medical Association
Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
